| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0003 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |